糖皮质激素可治性醛固酮增多症:一个中国人家系的临床和基因突变研究

目的:报告一个中国人糖皮质激素可治性醛固酮增多症(GRA)家系,探讨其诊治方法和发病机制。方法:对家系中的患病者进行了醛固酮、皮质醇和肾素活性动态检测,并对3名患者实施了地塞米松诊断性治疗。用长距离聚合酶链反应和DNA测序方法检测该系中11β-羟化酶基因和醛固酮合酶基因是否发生不等位交换。结果:家系中共有4人发病,均有不同程度的高血压、低血钾,血浆醛固酮正常高限,血浆肾素活性降低且不被激发(0.017±0.015ng·ml^-1·h^-1vs 0.130±0.080ng·ml·h^-1)。3名患者经2mg地塞米松治疗5天后,血浆醛固酮由(192±9)ng/L降至(87±7)ng/L(P<...

Full description

Saved in:
Bibliographic Details
Published inChinese medical journal Vol. 115; no. 7; pp. 979 - 982
Main Author 丁伟 刘礼斌 等
Format Journal Article
LanguageChinese
English
Published 上海第二医科大学附属瑞金医院,上海市内分泌研究所,上海,200025%福建医科大学附属省协和医院内分泌科,福州,350001 2002
Subjects
Online AccessGet full text

Cover

Loading…
Abstract 目的:报告一个中国人糖皮质激素可治性醛固酮增多症(GRA)家系,探讨其诊治方法和发病机制。方法:对家系中的患病者进行了醛固酮、皮质醇和肾素活性动态检测,并对3名患者实施了地塞米松诊断性治疗。用长距离聚合酶链反应和DNA测序方法检测该系中11β-羟化酶基因和醛固酮合酶基因是否发生不等位交换。结果:家系中共有4人发病,均有不同程度的高血压、低血钾,血浆醛固酮正常高限,血浆肾素活性降低且不被激发(0.017±0.015ng·ml^-1·h^-1vs 0.130±0.080ng·ml·h^-1)。3名患者经2mg地塞米松治疗5天后,血浆醛固酮由(192±9)ng/L降至(87±7)ng/L(P<0.05),2周及2个月后分别为(66±12)ng/L和(89±13)ng/L。一名患者对治疗反应较好,血钾治疗前为2.5mEq/L,用药35天后升至4.15mEq/L;血压也有所下降,从第一周的(146.3±10.7/94.6±5.3)mmHg,第3周降至(138.3±3.1。87.3±6.1)mmHg(P<0.05)。先证者及其胞姐尽管血浆醛固酮显著下降,临床症状仅有轻微改善,加用安体舒通和氧化钾片后才达正常。在该家系的所有4名受累者中,均可以扩增出长度为3.9kb的异常条带。不等位交换的基因断裂点均位于11β-羟化酶基因和醛固酮合酶基因的第2号内含子中。结论:GRA中过高的盐皮质激素可被外源性糖皮质激素所抑制。11β-羟化酶基因和醛固酮合要不得基因不等位交换是本家系的分子生物学发病机制。
AbstractList 目的:报告一个中国人糖皮质激素可治性醛固酮增多症(GRA)家系,探讨其诊治方法和发病机制。方法:对家系中的患病者进行了醛固酮、皮质醇和肾素活性动态检测,并对3名患者实施了地塞米松诊断性治疗。用长距离聚合酶链反应和DNA测序方法检测该系中11β-羟化酶基因和醛固酮合酶基因是否发生不等位交换。结果:家系中共有4人发病,均有不同程度的高血压、低血钾,血浆醛固酮正常高限,血浆肾素活性降低且不被激发(0.017±0.015ng·ml^-1·h^-1vs 0.130±0.080ng·ml·h^-1)。3名患者经2mg地塞米松治疗5天后,血浆醛固酮由(192±9)ng/L降至(87±7)ng/L(P<0.05),2周及2个月后分别为(66±12)ng/L和(89±13)ng/L。一名患者对治疗反应较好,血钾治疗前为2.5mEq/L,用药35天后升至4.15mEq/L;血压也有所下降,从第一周的(146.3±10.7/94.6±5.3)mmHg,第3周降至(138.3±3.1。87.3±6.1)mmHg(P<0.05)。先证者及其胞姐尽管血浆醛固酮显著下降,临床症状仅有轻微改善,加用安体舒通和氧化钾片后才达正常。在该家系的所有4名受累者中,均可以扩增出长度为3.9kb的异常条带。不等位交换的基因断裂点均位于11β-羟化酶基因和醛固酮合酶基因的第2号内含子中。结论:GRA中过高的盐皮质激素可被外源性糖皮质激素所抑制。11β-羟化酶基因和醛固酮合要不得基因不等位交换是本家系的分子生物学发病机制。
R5; 目的 报告一个中国人糖皮质激素可治性醛固酮增多症(GRA)家系,探讨其诊治方法和发病机制。方法 对家系中的患病者进行了醛固酮、皮质醇和肾素活性动态检测,并对3名患者实施了地塞米松诊断性治疗。用长距离聚合酶链反应和DNA测序方法检测该家系中11β-羟化酶基因和醛固酮合酶基因是否发生不等位交换。 结果 家系中共有4人发病,均有不同程度的高血压,低血钾,血浆醛固酮正常高限,血浆肾素活性降低且不被激发(0.017±0.015 ng*ml-1*h-1 vs 0.130±0.080 ng*ml-1*h-1)。3名患者经2 mg地塞米松治疗5天后,血浆醛固酮由(192±9)ng/L降至(87±7)ng/L(P<0.05),2周及2个月后分别为(66±12)ng/L 和(89±13)ng/L。一名患者对治疗反应较好,血钾治疗前为2.5 mEq*L-1,用药35天后升至4.15 mEq/L;血压也有所下降,从第一周的(146.3±10.7/94.6±5.3)mm Hg,第3周降至(138.3±3.1/87.3 ±6.1)mm Hg (P<0.05)。先证者及其胞姐尽管血浆醛固酮显著下降,临床症状仅有轻微改善,加用安体舒通和氯化钾片后才达正常。在该家系的所有4名受累者中,均可以扩增出长度为3.9 kb的异常条带。不等位交换的基因断裂点均位于11β-羟化酶基因和醛固酮合酶基因的第2号内含子中。 结论 GRA中过高的盐皮质激素可被外源性糖皮质激素所抑制。11β-羟化酶基因和醛固酮合酶基因不等位交换是本家系的分子生物学发病机制。
Abstract_FL Objective To report the clinical characteristics, biochemical profiles, diagnosis and treatment of one Chinese pedigree with glucocorticoid-remediable aldosteronism (GRA) and to study its molecular mechanism. Methods Plasma and urinary aldosterone, cortisol and plasma renin activities were dynamically tested and diagnostic therapy with dexamethasone was undergone in 3 affected subjects. Long-distance PCR as well as DNA sequencing were applied to detect the fusion gene in this pedigree. Results In this GRA pedigree, there were 4 affected subjects who had hypertension, hypokalemia and low basic and provoked renin activity. Three patients were given dexamethasone treatment, and had a significant decrease in plasma aldosterone concentrations (PACs) (from 192±9 ng/L to 87±7 ng/L, P<0.05) after 5 days. Among them, one patient (Ⅱ-3) responded quite satisfactorily to the therapy, with serum K+ rising from baseline value of 2.5 to 2.9, 3.8 and 4.15 mEq/L on the 10th, 28th and 35th days after treatment respectively. Three weeks later, his blood pressure decreased from its original level of 146.3±10.7/94.6±5.3 mm Hg to 138.3±3.1/87.3±6.1 mm Hg (P<0.05). The other 2 members (Ⅲ-2 and Ⅲ-4) showed modest improvement although their PACs decreased significantly. Using long-distance PCR, we found a 3.9 kb band in all 4 affected individuals, which was absent in 5 unaffected members from this pedigree or 8 patients with aldosterone-producing adenoma (APA) or idiopathic hyperaldosteronism (IHA). By DNA sequence analysis, we found that the breakpoint of "unequal crossing-over" is both within intron 2 of the 11β-hydroxylase gene (CYP11B1) and the aldosterone synthase gene (CYP11B2).Conclusions The excess of mineralocorticoid in patients with GRA can be inhibited by exogenous glucocorticoids. The fusion gene resulting from unequal crossing-over between the 11β-hydroxylase gene and the aldosterone synthase gene is the pathogenesis of this Chinese GRA pedigree.
Author 丁伟 刘礼斌 等
AuthorAffiliation 上海第二医科大学附属瑞金医院上海市内分泌研究所,上海200025 福建医科大学附属协和医院内分泌科,福州350001
AuthorAffiliation_xml – name: 上海第二医科大学附属瑞金医院,上海市内分泌研究所,上海,200025%福建医科大学附属省协和医院内分泌科,福州,350001
Author_FL DING Wei
LIU Libin
HU Renming
XU Manyin
CHEN Jialun
Author_FL_xml – sequence: 1
  fullname: DING Wei
– sequence: 2
  fullname: LIU Libin
– sequence: 3
  fullname: HU Renming
– sequence: 4
  fullname: XU Manyin
– sequence: 5
  fullname: CHEN Jialun
Author_xml – sequence: 1
  fullname: 丁伟 刘礼斌 等
BookMark eNo90MtKw0AYBeBBKthWH0IQd4mTzGSm406KNyi46b4madKLNUWDCK4qeAERCiIqCWgRQS1YwZYSUsWXyXTsylcwUnF1Fufj_-GkQMKpOxYAcwqUESVwoSpXXNdZhIgQiTDGZBVCVYZUhhBPgKSqYVXSCFYSIPlvpkDKdaux0zRKkmBTdK-E1_nqPQ0_G6LX4s3X4dtg2HgcnfjcD0fHHX5_yx88cX36_e5FQSMK2lHwwv2PKAx5py-6A-EdRUGPh2f84pzfhdxvifYhb96I1qV47k-DSVuvudbMX6ZBfmU5n12Tchur69mlnGRqFEsEIqwgrUgyDGdMaEBCFWIzHVqKomNoMiXuDcW0IWY6NmyziDDRLINaqo0NjFAazI_P7uuOrTulQrW-t-vEDwsHZXO7-jsMpPEsMZwdQ7Ncd0o7lZgaurllV2pWgaoZRglDP6QuiWw
ClassificationCodes R5
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3760/j.issn:0366-6999.2002.07.004
DatabaseName 中文科技期刊数据库
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitle_FL Clinical and gene mutation studies on a Chinese pedigree with glucocorticoid-remediable aldosteronism
EISSN 2542-5641
EndPage 982
ExternalDocumentID zhcmj200207004
7289769
GrantInformation_xml – fundername: 国家自然科学基金
  funderid: (39570345)
GroupedDBID ---
-05
-0E
-SE
-S~
.55
.GJ
29B
2B.
2C~
2RA
2WC
3V.
40I
53G
5GY
5RE
5VR
5VS
6J9
7X7
88E
8FI
8FJ
92F
92I
92L
92M
93N
93R
9D9
9DE
AABQG
AAHPQ
AALRV
AAPBV
ABASU
ABDIG
ABFLS
ABUWG
ABXLX
ACGFO
ACGFS
ADGIM
ADPDF
ADRAZ
AENEX
AFDTB
AFKRA
AFUIB
AHMBA
AHVBC
AJIOK
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
BBAFP
BENPR
BPHCQ
BVXVI
C1A
CAJEE
CAJUS
CCEZO
CDYEO
CHBEP
CIEJG
CQIGP
CW9
CXBCV
DIK
DIWNM
EBS
EJD
F5P
FA0
FRP
FYUFA
GQDEL
GROUPED_DOAJ
GX1
H13
HYE
IAO
IHR
IHW
IKREB
INH
INR
IPNFZ
ITC
JUIAU
KQ8
L7B
M1P
M48
N95
OK1
OLW
OPUJH
OVD
OVDNE
OVEED
OXXIT
P2P
P6G
PIMPY
PQEST
PQQKQ
PQUKI
PROAC
PSQYO
PV9
Q--
Q-4
R-E
RIG
RNS
RPM
RT5
RZL
S..
T8U
TCJ
TEORI
TGQ
TR2
TSPGW
U1F
U1G
U5E
U5O
UKHRP
W2D
W91
WFFXF
X7J
X7M
XSB
ZA5
ZGI
ZXP
~WA
0R~
4A8
AAAAV
AAIQE
AASCR
ABCQX
ABVCZ
ABZZY
ACILI
ACXJB
ADGGA
ADHPY
AFBFQ
AHQNM
AINUH
AJCLO
AJNWD
AJZMW
AKCTQ
ALIPV
ALKUP
AMNEI
AOHHW
AOQMC
BQLVK
CCPQU
EEVPB
FCALG
GNXGY
HLJTE
HMCUK
PHGZM
PHGZT
PMFND
PSX
RLZ
ID FETCH-LOGICAL-c574-6034135d68948c0b06716f9a0e11a40c91341b1cf049a4bfcd3465eb7e2f4b433
ISSN 0366-6999
IngestDate Thu May 29 04:01:06 EDT 2025
Thu Nov 24 20:29:10 EST 2022
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords 醛固酮增多症
醛固酮
肾素
glucocorticoid
fusion gene
融合基因
aldosterone
renin
aldosteronism
糖皮质激素类
Language Chinese
English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c574-6034135d68948c0b06716f9a0e11a40c91341b1cf049a4bfcd3465eb7e2f4b433
Notes R586.24
11-2154/R
PageCount 4
ParticipantIDs wanfang_journals_zhcmj200207004
chongqing_backfile_7289769
PublicationCentury 2000
PublicationDate 2002
PublicationDateYYYYMMDD 2002-01-01
PublicationDate_xml – year: 2002
  text: 2002
PublicationDecade 2000
PublicationTitle Chinese medical journal
PublicationTitleAlternate Chinese Medical Journal
PublicationTitle_FL CHINESE MEDICAL JOURNAL
PublicationYear 2002
Publisher 上海第二医科大学附属瑞金医院,上海市内分泌研究所,上海,200025%福建医科大学附属省协和医院内分泌科,福州,350001
Publisher_xml – name: 上海第二医科大学附属瑞金医院,上海市内分泌研究所,上海,200025%福建医科大学附属省协和医院内分泌科,福州,350001
SSID ssj0025576
ssib001521049
ssib051457378
ssib044732928
ssib008142972
ssib038074633
ssib017628699
ssib058574914
ssib020751800
ssib001103466
ssib022315857
ssib000827134
ssib006703066
ssib058492515
ssib051368197
Score 1.6319001
Snippet ...
R5; 目的 报告一个中国人糖皮质激素可治性醛固酮增多症(GRA)家系,探讨其诊治方法和发病机制。方法 对家系中的患病者进行了醛固酮、皮质醇和肾素活性动态检测,并对3名患者实施了地塞米松诊断性治疗。用长距离聚合酶链反应和DNA测序方法检测该家系中11β-羟化酶基因和醛固酮合酶基因是否发生不等位交换。 结果...
SourceID wanfang
chongqing
SourceType Aggregation Database
Publisher
StartPage 979
SubjectTerms GRA
基因突变
家系报告
糖皮质激素类
融合基因
醛固酮
醛固酮增多症
Title 糖皮质激素可治性醛固酮增多症:一个中国人家系的临床和基因突变研究
URI http://lib.cqvip.com/qk/85656X/20027/7289769.html
https://d.wanfangdata.com.cn/periodical/zhcmj200207004
Volume 115
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1da9RAcGkrFF-kfmGr1j50n0pqLtlsdn1LrheLUJ8q9O287CUtile07UufKvgBIhREVO5AiwhqwQq2lOOq-GcujX3yLzg7yZ1HKaISWIa53Zndnc3tzGZ2hpBx0FG5Ug43QqVsg2kPMckjZkSKK5u5VlwN9Rfdmet8-ga7NufM9fUP9XgtrSyHk2r1yHsl_yNVwIFc9S3Zf5BslyggAAb5QgkShvKvZExLLvVtKrkGpEe9Ei0J6jPqCVri1A-0H4OuAxgAHCoC6gX4k0V9XwNQwXNpSVLBqfR1HSh9DzEOEoTSojIDmOaieblUQKuA-kXEMOoL5IWA18F4Ux2CU4jxkDKS9Xneed0N7LxgeSvoLdSBmgIrS4uKIgJB3hwIejguYCQK-bikQIxJJUNAAotezVsnCo-WosyZ4HfIjM6C64yhgACMKphAwqJDGLEwYTDZojiBqCma5SXqnpr0HqHanBtcZmmZJiPEgZUMJjnPQnB194Xsnmn-Arg9__LSlT0Kg8yyJx3ei7S3Ee5FmgOsmy5f9IvBiLFZ4uVD8b5dMIFdLvvJMQssH73XXJ3rei2BAejmn98zYoNkPOd1OeN05Ug-OnLIwmJt_i7oQ3g9rRZXavM9mtTsEDmRm0BjXraeT5K-qHaKDM7kTh6nyc10-0Va3_qx82H_-1q6s5Gsf97_sre_9v7gUSNptA4ebiVvXyfv6unLxz-_1tvNtXZzs938lDS-tVutZGs33d5L6w_azZ2k9SR59jR500oaG-nm_WT9VbrxPP24e4bMBqXZ4rSRJwIxlOMyg5ta1XKqXEgmlBmCglXgsayYUaFQYabSziOFsKBisHYrLIxV1WbciUI3smIWMts-SwZqi7XoHBlTVXgcYdpVO2JWFId2taJsN-S2JYVbjYfJSHeeQI9Ut3V0tHIukmFyKZ-4cr5Gl8qrC-rOLT3Rps4TMfKn5ufJcUwlhOd3F8jA8r2V6CJotMvhKJ4EjaKkfwFrbZOS
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E7%B3%96%E7%9A%AE%E8%B4%A8%E6%BF%80%E7%B4%A0%E5%8F%AF%E6%B2%BB%E6%80%A7%E9%86%9B%E5%9B%BA%E9%85%AE%E5%A2%9E%E5%A4%9A%E7%97%87%EF%BC%9A%E4%B8%80%E4%B8%AA%E4%B8%AD%E5%9B%BD%E4%BA%BA%E5%AE%B6%E7%B3%BB%E7%9A%84%E4%B8%B4%E5%BA%8A%E5%92%8C%E5%9F%BA%E5%9B%A0%E7%AA%81%E5%8F%98%E7%A0%94%E7%A9%B6&rft.jtitle=Chinese+medical+journal&rft.au=%E4%B8%81%E4%BC%9F+%E5%88%98%E7%A4%BC%E6%96%8C+%E7%AD%89&rft.date=2002&rft.issn=0366-6999&rft.eissn=2542-5641&rft.volume=115&rft.issue=7&rft.spage=979&rft.epage=982&rft_id=info:doi/10.3760%2Fj.issn%3A0366-6999.2002.07.004&rft.externalDocID=7289769
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85656X%2F85656X.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzhcmj%2Fzhcmj.jpg